fluorodeoxyglucose f18 has been researched along with TDP-43 Proteinopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boeve, BF; Botha, H; Buciuc, M; Dickson, DW; Jack, CR; Jones, DT; Josephs, KA; Knopman, DS; Lowe, V; Murray, ME; Parisi, JE; Petersen, RC; Petrucelli, L; Schwarz, CG; Senjem, ML; Whitwell, JL | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and TDP-43 Proteinopathies
| Article | Year |
|---|---|
Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; TDP-43 Proteinopathies | 2020 |